Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
This study is ongoing, but not recruiting participants.
Study NCT00996060   Information provided by New Mexico Cancer Care Alliance

First Received on March 26, 2009.   Last Updated on March 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Cancer
Additional conditions recognized in this trial
Lung Neoplasms
More general conditions related to this trial
Lung Diseases
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
Hydralazine and Valproic Acid
Additional drug interventions recognized in this trial
Hydralazine
Valproic Acid
More general drug interventions related to this trial
Anticonvulsants
Antihypertensive Agents
Antimanic Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Vasodilator Agents
Sponsors listed in this trial
New Mexico Cancer Care Alliance


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services